|Articles|February 1, 2018
- BioPharm International-02-01-2018
- Volume 31
- Issue 2
BioPharm International, February 2018 Issue (PDF)
Click the title above to open the BioPharm International February 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 8 years ago
Impurity Testing of Biologic Drug Productsalmost 8 years ago
The Ins and Outs of LC-Based Analytical Tools and Techniquesalmost 8 years ago
Tabletop Peristaltic Liquid-Filling Machinealmost 8 years ago
USB Data Logger for Temperature-Sensitive Productsalmost 8 years ago
Maintaining Lab Data Integrityalmost 8 years ago
Navigating Data Integrity in the Modern Labalmost 8 years ago
Designing a Single-Use Biopharmaceutical Processalmost 8 years ago
Container Closures: Leaving Nothing to Chancealmost 8 years ago
A New Business Model for Pharma?almost 8 years ago
FDA Framework Spurs Advanced TherapiesNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Ultragenyx Phase III Data Reveal Limits of Bone Density Endpoints in Rare Bone Disease
2
Biopharma’s 2025 Transformation: A Recap of Our Top 10 Articles
3
Building Robust Biomanufacturing Networks for the Next Wave of Therapies
4
Accelerate Your Biologic with HEK Cell Lines
5
